Xiao Yu

1.9k citations
44 papers · 1.2k indexed · 1 hit paper · h-index 16
Topics
Pancreatitis Pathology and Treatment (12 papers)Pancreatic and Hepatic Oncology Research (8 papers)Phagocytosis and Immune Regulation (7 papers)

In The Last Decade

Xiao Yu

43 papers receiving 1.2k citations

Hit Papers

Single-cell analyses reveal key immune cell subsets assoc...20212026202220242021100200300400

Peers

Xiao Yu
Comparison fields: 5 of 99
  • Oncology 481
  • Molecular Biology 478
  • Immunology 401
  • Surgery 236
  • Cancer Research 208
Replace Armel Hervé Nwabo Kamdje with:
Armel Hervé Nwabo Kamdje Cameroon
Yang Fu China
Fujun Li China
Chifumi Fujii Japan
Yuqin Yao China
Chao‐Wen Cheng Taiwan
Arash Soltani Iran
Fan Sun China
Feng Xie China
Adil Akhtar United States
Xiao Yu relative to Armel Hervé Nwabo Kamdje Cameroon Armel Hervé Nwabo Kamdje's profile →
Citations per field
00.5×3.3×
Armel Hervé Nwabo Kamdje · 1×
Citations per year

Countries citing papers authored by Xiao Yu

Since Specialization
Citations

This map shows the geographic impact of Xiao Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao Yu more than expected).

Fields of papers citing papers by Xiao Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao Yu. The network helps show where Xiao Yu may publish in the future.

Co-authorship network of co-authors of Xiao Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao Yu. A scholar is included among the top collaborators of Xiao Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao Yu. Xiao Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 3
4 9
5 7
6 0
7 1
8 7
9 4
10
Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancerbreakdown →
434
11 9
12 20
13 57
14 13
15 46
16 4
17 36
18 15
19 22
20 18

About Xiao Yu

Xiao Yu is a scholar working on Immunology, Oncology and Surgery, having authored 44 papers that have together received 1.2k indexed citations. Recurring topics across this work include Pancreatitis Pathology and Treatment (12 papers), Pancreatic and Hepatic Oncology Research (8 papers) and Phagocytosis and Immune Regulation (7 papers). The work is most often cited by research in Immunology (401 citations), Oncology (481 citations) and Cancer Research (208 citations). Xiao Yu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Hongwei Zhu, Cheng Peng, Zhihua Liu, Baolin Liu, Qing Chang, Yong Wang, Ranran Gao, Xiaoying Sun, Yahui Zhao and Ting Hu. Their work appears in journals such as Cancer Cell, Scientific Reports and Chemical Engineering Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026